BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18669503)

  • 1. Comment on 'Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle'.
    Greenberg SA
    Brain; 2009 Apr; 132(Pt 4):e106; author reply e107. PubMed ID: 18669503
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
    Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
    Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
    Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC
    Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
    Wójcik S; Engel WK; McFerrin J; Askanas V
    Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model.
    Wojcik S; Nogalska A; McFerrin J; Engel WK; Oledzka G; Askanas V
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):238-42. PubMed ID: 17359364
    [No Abstract]   [Full Text] [Related]  

  • 6. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
    Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
    Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
    Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes.
    Finch CE
    Neurology; 2006 Jan; 66(2 Suppl 1):S1-6. PubMed ID: 16432135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
    Fidziańska A; Glinka Z
    Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion body myositis: new insights into pathogenesis.
    Garlepp MJ; Mastaglia FL
    Curr Opin Rheumatol; 2008 Nov; 20(6):662-8. PubMed ID: 18946325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology and pathogenesis of inclusion-body myositis.
    Askanas V; Engel WK
    Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
    Askanas V; Engel WK
    Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sporadic inclusion body myositis and amyloid].
    Aoki M; Suzuki N
    Brain Nerve; 2014 Jul; 66(7):739-48. PubMed ID: 24998819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.
    Niedowicz DM; Beckett TL; Holler CJ; Weidner AM; Murphy MP
    Neurosci Lett; 2010 Sep; 482(1):57-61. PubMed ID: 20621159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct forms of hyperphosphorylated tau in sporatic versus hereditary inclusion myopathy.
    Rosenblum WI
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1179-80. PubMed ID: 8939201
    [No Abstract]   [Full Text] [Related]  

  • 16. Macroautophagy as a pathomechanism in sporadic inclusion body myositis.
    Lünemann JD; Schmidt J; Dalakas MC; Münz C
    Autophagy; 2007; 3(4):384-6. PubMed ID: 17438365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prevention of the amyloidoses: can the lessons learned be applied to sporadic inclusion-body myositis?
    Buxbaum JN
    Neurology; 2006 Jan; 66(2 Suppl 1):S110-3. PubMed ID: 16432137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.
    Boncompagni S; Moussa CE; Levy E; Pezone MJ; Lopez JR; Protasi F; Shtifman A
    J Biol Chem; 2012 Jun; 287(24):20534-44. PubMed ID: 22518836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic inclusion body myositis: a continuing puzzle.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2008 Jan; 18(1):6-16. PubMed ID: 18160291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I in inclusion-body myositis and human muscle cultures.
    Broccolini A; Ricci E; Pescatori M; Papacci M; Gliubizzi C; D'Amico A; Servidei S; Tonali P; Mirabella M
    J Neuropathol Exp Neurol; 2004 Jun; 63(6):650-9. PubMed ID: 15217093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.